NADH RAPID
Commercial- Indications
- Energy production, Mental performance
Company intelligence / Profile preview
Prof. George Birkmayer NADH
Vienna, Vienna, Austriaen.birkmayer-nadh.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company commercializes stabilized, bioavailable NADH supplements developed by Prof. George Birkmayer. Numerous clinical studies have substantiated efficacy for neurodegenerative diseases, chronic fatigue syndrome, depression, aging-related conditions, and visual health. Products are vegetarian-friendly and formulated without common allergens or additives.
Clinical results include improved cognitive function in Alzheimer’s/Parkinson’s patients and enhanced energy/metabolic performance in CFS sufferers.
- Therapeutic areas
- ImmunologyOtherPsychiatryOphthalmologyNeurology
- Modalities
- Small molecule nutraceuticals (NADH-based supplements)
- Industry
- Food & Nutrition
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Distribution partnerships worldwide for supplement sales; no major pharma co-development deals noted.
Beyond the preview
Go deeper on Prof. George Birkmayer NADH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Prof. George Birkmayer NADH.